Clinical Trial: Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis

U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07291284) titled 'Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis' on Dec. 05.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy and safety of LP-003 injection in patients with moderate to severe seasonal allergic rhinitis inadequately controlled by standard-of-care.

Study Start Date: Aug. 01, 2024

Study Type: INTERVENTIONAL

Condition: Seasonal Allergic Rhinitis

Intervention: BIOLOGICAL: LP-003

Participants were administered LP-003 via subcutaneous injection every 4 weeks.

BIOLOGICAL: Placebo

Participants ...